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Abstract
Introduction: Whether acute pancreatitis can occur in pancreatically insufficient individuals with cystic fibrosis
remains a matter of debate.
Case presentation: We describe a case of acute pancreatitis occurring in a 52-year-old Caucasian Australian man
with moderately severe cystic fibrosis lung disease and pancreatic insufficiency. An inflammatory mass within the
head of his pancreas was confirmed using computed tomography, magnetic resonance imaging and pancreatic
biopsy, but serum amylase and lipase remained normal throughout the acute phase of his illness. His symptoms
and the pancreatic mass resolved following the insertion of a biliary stent and the introduction of ursodeoxycholic
acid.
Conclusion: Our case report highlights the potential for acute pancreatitis to occur in patients with pancreatic
insufficiency and cystic fibrosis. We further demonstrate that conventional biochemical markers that are normally
assessed to confirm the diagnosis may not be of particular use. As patients with cystic fibrosis survive into their
fourth and fifth decades of life, atypical presentations of acute pancreatitis may become more common.
Introduction
Acute pancreatitis in cystic fibrosis occurs almost exclu-
sively in young patients with pancreatic sufficiency [1].
We describe the case of a 53-year-old man with cystic
fibrosis and pancreatic insufficiency who presented with
abdominal pain and a diagnosis of acute pancreatitis
despite normal amylase and lipase levels in his periph-
eral blood.
Case presentation
A 52-year-old Australian Caucasian male with cystic
fibrosis was admitted to our hospital with an exacerba-
tion of pulmonary sepsis accompanied by a vague
abdominal pain. Abdominal X-ray revealed faecal load-
ing in his caecum and ascending colon with proximal
small bowel dilatation consistent with meconium ileus
equivalent. His relevant medical history consisted of
pancreatic insufficiency and bronchiectasis with
moderately severe lung function impairment (FEV1 2.18
L/s; 53% predicted). He had multiple hospital admis-
sions over the preceding two years with exacerbations of
chronic airway sepsis.
The diagnosis of cystic fibrosis had been made during
his early childhood when he presented with failure to
thrive, and this had been confirmed with an elevated
sweat test and genotyping that revealed him to be a het-
erozygote for G542X, with the other allele unidentified.
G542X is a Class I mutation that results in the complete
failure to synthesize functional cystic fibrosis transmem-
brane conductance regulator (CFTR) and is usually asso-
ciated with pancreatic insufficiency. On this particular
admission, his chest and abdominal symptoms resolved
after a course of intravenous antibiotics, fluid replace-
ment, and oral administration of N-acetyl cysteine. His
24-hour fecal fat levels were elevated at 41 grams and
his pancreatic enzymes were thus increased.
He presented again after six weeks due to a recurrence
of severe abdominal pain, anorexia and weight loss, but
without any alteration to his bowel habit. Examination
revealed epigastric tenderness and active bowel sounds,
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but no guarding. Results of respiratory examination
were unchanged. On this occasion, abdominal X-ray was
normal, as were his full blood count, urea and electro-
lytes, serum amylase (46 IU/L; NR < 100 IU/L), and
liver function tests. However, he continued to complain
of severe abdominal pain radiating through his back and
lower chest. An abdominal ultrasound demonstrated an
increased echogenicity consistent with inspissated secre-
tions in the pancreatic duct and an 8 mm common bile
duct with no other abnormalities.
Two days after admission, our patient became jaun-
diced. Repeat blood tests demonstrated a cholestatic pic-
ture: total protein 66 g/L, albumin 36 g/L, alkaline
phosphates (ALP) 809IU/L, alanine transaminase (ALT)
543IU/L, glutamyl transaminase (GGT) 334IU/L, and
bilirubin 23 mmol/L. His serum amylase (42IU/L) and
lipase (4IU/L; NR: < 10IU/L), as well as urinary lipase
(96IU/L, NR: < 500IU/L) levels remained normal. An
abdominal computed tomography (CT) scan demon-
strated that he had a heterogeneous mass measuring
5×5×5 cm and located at the head of the pancreas with
biliary and pancreatic duct dilation (Figure 1). Magnetic
resonance cholangiopancreatography confirmed the
enlargement of the head of his pancreas with dilated
intrahepatic and extrahepatic biliary ducts. These find-
ings were thought to be consistent with either acute
pancreatitis or a pancreatic malignancy.
Results of his liver function tests remained abnormal
(ALP 1085IU/L, ALT 249IU/L, GGT 383IU/L, and bilir-
ubin 37 μmol/L) and the patient proceeded to endo-
scopic retrograde cholangiopancreatography, where a
narrowing of the common bile duct at the head of the
pancreas was identified with more distal anatomical dis-
tortion of the entire pancreatic ductal system. A biliary
stent was consequently inserted. CT guided biopsy of
the pancreatic mass demonstrated reactive pancreatic
ductal epithelium with an infiltrate of macrophages and
lymphocytes, but no evidence of malignancy was found.
The patient continued to experience abdominal pain
and ursodeoxycholic acid was introduced to treat any
potential contribution of biliary sludging to cholestasis
and also to minimize the risk of stent occlusion. Follow-
ing stent insertion and commencement of ursodeoxy-
cholic acid, his symptoms and liver function tests slowly
improved, and then returned to normal over the next
6 weeks. A repeat CT scan showed a resolution of bili-
ary dilation, but no change in the pancreatic mass was
noted. After 18 months he remains well with normal
liver function tests and no abdominal pain. A repeat CT
scan at this time demonstrated a complete resolution of
the pancreatic mass (Figure 2).
Discussion
Although chronic pancreatitis is common in cystic fibro-
sis, acute pancreatitis is rare and usually occurs in young
patients who are pancreatically sufficient [1,2]. We are
unaware of any previous reports of acute pancreatitis
occurring in an older adult with pancreatic insufficiency
and cystic fibrosis but in the setting of normal amylase
and lipase. The few reports available concerning acute
pancreatitis in patients with pancreatic insufficiency
concern children or young adults and always with raised
amylase and lipase blood levels [1,3,4].
In our patient, acute pancreatitis was possibly related
to his abnormal pancreatic duct anatomy and the che-
mical insult of bile constituents causing direct damage
Figure 1 Computed tomography scan demonstrating mass at
the head of the pancreas.
Figure 2 Computed tomography scan at 18 months showing
resolution of the pancreatic inflammatory mass.
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to his pancreatic tissue, which was then followed by a
local inflammatory response. Despite these proposed
mechanisms there was no classical biochemical evidence
of pancreatic injury, although imaging confirmed a typi-
cal inflammatory mass and gross edema of the pancreas.
Clinical improvement was relatively rapid following bili-
ary stenting and the introduction of ursodeoxycholic
acid. A repeat CT scan demonstrated a complete resolu-
tion of the previous inflammatory mass.
When all other diagnoses have been excluded, the
poor diagnostic sensitivity of amylase and lipase in both
blood and urine samples have to be considered in older
patients with cystic fibrosis who present with abdominal
pain.
Conclusion
As patients with cystic fibrosis survive into their fourth
and fifth decades of life, atypical presentations of acute
pancreatitis may become more common. Caution needs
to be exercised when diagnosing acute pancreatitis in
patients with pancreatic insufficiency, as the biochemical
parameters normally used may not accurately reflect the
disease process.
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